Children and adolescents with type 1 diabetes using either an insulin pump, CGM, or both, have lower HbA1c and fewer DKA episodes than their peers who are not using diabetes technology, a new study suggests. Data from the international SWEET registry, comprising more than 25,000 participants across 101 centres, supports Australia’s CGM program for young ...
Type 1 diabetes
Glycaemic data supports case to make diabetes technology accessible to people of all ages with T1D
By Mardi Chapman
8 Jun 2021